Rapport Therapeutics Investor Relations Material

Rapport Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of small-molecule medicines targeting central nervous system disorders. The company's research focuses on understanding neuronal receptor biology to design precision treatments that address the complexities of neurological conditions. By mapping and targeting specific neuronal receptor complexes, Rapport aims to regulate receptor function and expression effectively. The company is headquartered in Boston, Massachusetts, and its shares are listed on NASDAQ.